APA (7th ed.) Citation

Jiyi Liang, Jiyi Liang, Wei Li, Honglin Liu, Xiaofen Li, Chuqiao Yuan, . . . Liping Qu. (2022). Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jiyi Liang, Jiyi Liang, Wei Li, Honglin Liu, Xiaofen Li, Chuqiao Yuan, Wenjun Zou, Liping Qu, and Liping Qu. Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Jiyi Liang, et al. Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Frontiers Media S.A., 2022.